{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:14:23Z","timestamp":1747167263327,"version":"3.40.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.mcp.2018.11.007","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T04:59:22Z","timestamp":1543467562000},"page":"40-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prediction of epitopes of Neisseria Gonorrhoeae against USA human leukocyte antigen background: An immunoinformatic approach towards development of future vaccines for USA population"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3614-0702","authenticated-orcid":false,"given":"Malik Siddique","family":"Mahmood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Asad-Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hina","family":"Batool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Batool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naeem Mehmood","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mcp.2018.11.007_bib1","first-page":"129","article-title":"Neisseria gonorrhoeae infections, Nihon rinsho","volume":"67","author":"Furuya","year":"2009","journal-title":"Jpn. J. Clin. Med."},{"year":"2017","series-title":"Sexually Transmitted Disease Surveillance 2016","author":"Braxton","key":"10.1016\/j.mcp.2018.11.007_bib2"},{"key":"10.1016\/j.mcp.2018.11.007_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/sti.2010.042648","article-title":"The Gonococcus fights back: is this time a knock out?","author":"Lewis","year":"2010","journal-title":"Sex. Transm. Infect."},{"issue":"4","key":"10.1016\/j.mcp.2018.11.007_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/ISB-2009-0399","article-title":"In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae","volume":"9","author":"Barh","year":"2009","journal-title":"In Silico Biol."},{"year":"2005","series-title":"Screening of neisserial Vaccine Candidates and Vaccines against Pathogenic neisseria","author":"Ala'Aldeen","key":"10.1016\/j.mcp.2018.11.007_bib5"},{"year":"2018","series-title":"Vaccines for Neisseria Gonorrhoeae","author":"Pizza","key":"10.1016\/j.mcp.2018.11.007_bib6"},{"issue":"14","key":"10.1016\/j.mcp.2018.11.007_bib7","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.vaccine.2013.08.067","article-title":"Vaccines against gonorrhea: current status and future challenges","volume":"32","author":"Jerse","year":"2014","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"10.1016\/j.mcp.2018.11.007_bib8","doi-asserted-by":"crossref","first-page":"iv63","DOI":"10.1136\/sextrans-2013-051225","article-title":"Vaccine research for gonococcal infections: where are we?","volume":"89","author":"Jerse","year":"2013","journal-title":"Sex. Transm. Infect."},{"issue":"3","key":"10.1016\/j.mcp.2018.11.007_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00382-15","article-title":"Thinking globally, acting locally: harnessing the immune system to deal with recalcitrant pathogens","volume":"6","author":"Russell","year":"2015","journal-title":"MBio"},{"issue":"4","key":"10.1016\/j.mcp.2018.11.007_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0952-7915(03)00083-9","article-title":"Epitope-based vaccines: an update on epitope identification, vaccine design and delivery","volume":"15","author":"Sette","year":"2003","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.mcp.2018.11.007_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6026\/97320630005077","article-title":"A novel strategy of epitope design in Neisseria gonorrhoeae","volume":"5","author":"Barh","year":"2010","journal-title":"Bioinformation"},{"issue":"3","key":"10.1016\/j.mcp.2018.11.007_bib12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4172\/jpb.1000125","article-title":"In silico identification of dual ability of N. gonorrhoeae ddl for developing drug and vaccine against pathogenic Neisseria and other human pathogens","volume":"3","author":"Barh","year":"2010","journal-title":"JPB"},{"key":"10.1016\/j.mcp.2018.11.007_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.meegid.2016.05.009","article-title":"In-silico analysis of putative HCV epitopes against Pakistani human leukocyte antigen background: an approach towards development of future vaccines for Pakistani population","volume":"43","author":"Ashraf","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.mcp.2018.11.007_bib14","series-title":"The Genetic Codes","first-page":"16","author":"Elsanowski","year":"1996"},{"key":"10.1016\/j.mcp.2018.11.007_bib15","series-title":"Allele Frequency Net Database, HLA Typing","first-page":"49","author":"Gonzalez-Galarza","year":"2018"},{"issue":"D1","key":"10.1016\/j.mcp.2018.11.007_bib16","doi-asserted-by":"crossref","first-page":"D405","DOI":"10.1093\/nar\/gku938","article-title":"The immune epitope database (IEDB) 3.0","volume":"43","author":"Vita","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.mcp.2018.11.007_bib17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T\u2010cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.mcp.2018.11.007_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2105-10-296","article-title":"An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction","volume":"10","author":"Nielsen","year":"2009","journal-title":"BMC Bioinf."},{"issue":"1","key":"10.1016\/j.mcp.2018.11.007_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.mcp.2018.11.007_bib20","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2105-14-S6-S4","article-title":"AllerTOP-a server for in silico prediction of allergens","author":"Dimitrov","year":"2013","journal-title":"BMC Bioinf. BioMed. Central"},{"issue":"12","key":"10.1016\/j.mcp.2018.11.007_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00894-001-0058-5","article-title":"New quantitative descriptors of amino acids based on multidimensional scaling of a large number of physical\u2013chemical properties","volume":"7","author":"Venkatarajan","year":"2001","journal-title":"Mol. Model. Annu."},{"issue":"1","key":"10.1016\/j.mcp.2018.11.007_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.mcp.2018.11.007_bib23","first-page":"65","article-title":"In silico identification of membrane associated candidate drug targets in Neisseria gonorrhoeae","volume":"6","author":"Barh","year":"2009","journal-title":"In Silico Biol."},{"issue":"3","key":"10.1016\/j.mcp.2018.11.007_bib24","first-page":"82","article-title":"In silico identification of dual ability of N. gonorrhoeae ddl for developing drug and vaccine against pathogenic Neisseria and other human pathogens","volume":"3","author":"Barh","year":"2010","journal-title":"In Silico Biol."},{"issue":"28","key":"10.1016\/j.mcp.2018.11.007_bib25","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.2174\/138161210793292447","article-title":"Epitope discovery and their use in peptide based vaccines","volume":"16","author":"Dudek","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.mcp.2018.11.007_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fmicb.2011.00124","article-title":"Vaccines for gonorrhea: can we rise to the challenge?","volume":"2","author":"Zhu","year":"2011","journal-title":"Front Microbiol."},{"issue":"4","key":"10.1016\/j.mcp.2018.11.007_bib27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/CJI.0b013e31816dad10","article-title":"A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer","volume":"31","author":"Chianese-Bullock","year":"2008","journal-title":"J. Immunother."},{"issue":"2","key":"10.1016\/j.mcp.2018.11.007_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6026\/97320630005077","article-title":"A novel strategy of epitope design in Neisseria gonorrhoeae","volume":"5","author":"Barh","year":"2010","journal-title":"Bioinformation"},{"issue":"2","key":"10.1016\/j.mcp.2018.11.007_bib29","doi-asserted-by":"crossref","DOI":"10.1590\/S0100-879X1999000200008","article-title":"MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans","volume":"32","author":"Cunha-Neto","year":"1999","journal-title":"Braz. J. Med. Biol. Res."}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089085081830238X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089085081830238X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T07:30:40Z","timestamp":1605511840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089085081830238X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":29,"alternative-id":["S089085081830238X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2018.11.007","relation":{},"ISSN":["0890-8508"],"issn-type":[{"type":"print","value":"0890-8508"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of epitopes of Neisseria Gonorrhoeae against USA human leukocyte antigen background: An immunoinformatic approach towards development of future vaccines for USA population","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}